Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05468918 · ClinicalTrials.gov registry record · NA
Real World Perspectives on Advancements in Hearing Aid Technology
A NA study of Hearing Loss, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT05468918: Completed NA study of Hearing Loss, sponsored by Sonova.
NCT05468918 is a NA study of Hearing Loss that has completed, run by Sonova. The registered enrollment target is 14 participants, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05468918, a NA study of Hearing Loss, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare different microphone technologies in a noisy environment when the dominant speaker is at the front, back, left, or right side of the listener.
Primary Outcome
A speech in noise test in which participants repeat words which are presented in the presence of background noise. In a 12-speaker array, speech is presented from speakers either on the left side of the participant (-90 degrees) or from behind the participant (180 degrees) while background noise is presented from remaining speakers. Scores are calculated as the number of words correctly repeated and expressed as a percentage. A higher percentage or score is better.
Conditions Studied
Interventions
- DEVICE Phonak Audeo previous generation hearing aids
- DEVICE Phonak Audeo Lumity hearing aids
Study Locations (1)
Illinois
- Phonak Audiology Research Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
What the finished NCT05468918 record still lists
NCT05468918 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 6,121-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Phonak Audeo previous generation hearing aids is the first listed.
NCT05468918 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05468918 about?
NCT05468918 is a clinical study titled "Real World Perspectives on Advancements in Hearing Aid Technology". This study will compare different microphone technologies in a noisy environment when the dominant speaker is at the front, back, left, or right side of the listener.
What is the current status of trial NCT05468918?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-07-18. Estimated completion is 2022-10-26.
What conditions does trial NCT05468918 study?
This clinical trial studies the following conditions: Hearing Loss.
What interventions are being tested in trial NCT05468918?
The interventions under investigation include: Phonak Audeo previous generation hearing aids (DEVICE), Phonak Audeo Lumity hearing aids (DEVICE).
Who is sponsoring clinical trial NCT05468918?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05468918 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05468918's enrollment target sits among peer trials
14 59th of 58 the lowest of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy